We are live on ! Find out more
XENE icon

Xenon Pharmaceuticals
XENE

204 hedge funds and large institutions have $3.33B invested in Xenon Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 86 increasing their positions, 51 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 19

69% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 51

59% more capital invested

Capital invested by funds: $2.1B → $3.33B (+$1.23B)

56% more funds holding in top 10

Funds holding in top 10: 9 → 14 (+5)

13% more funds holding

Funds holding: 180 → 204 (+24)

2.19% more ownership

Funds ownership: 95.63% → 97.83% (+2.2%)

4% less call options, than puts

Call options by funds: $39M | Put options by funds: $40.6M

Holders
204
Holders Change
+24
Holders Change %
+13.33%
% of All Funds
2.97%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.2%
New
46
Increased
86
Reduced
51
Closed
19
Calls
$39M
Puts
$40.6M
Net Calls
-$1.6M
Net Calls Change
+$6.69M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$86M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$49.6M
3
BlackRock
BlackRock
New York
+$38M
4
FLAM
First Light Asset Management
Minnesota
+$36.9M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$31.5M

Top Sellers

1
BI
BVF Inc
California
-$33.1M
2
NIP
Nicholas Investment Partners
California
-$27.1M
3
Marshall Wace
Marshall Wace
United Kingdom
-$22.1M
4
SC
Samlyn Capital
New York
-$18.7M
5
B
Braidwell
Connecticut
-$16.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Natixis Advisors
126
Natixis Advisors
Massachusetts
$980K -$25.8K -731 -3%
Stifel Financial
127
Stifel Financial
Missouri
$962K +$14.2K +401 +2%
CIP
128
Chartwell Investment Partners
Pennsylvania
$945K -$98.3K -2,781 -12%
ACM
129
Aquatic Capital Management
Illinois
$898K +$148K +4,200 +27%
SG Americas Securities
130
SG Americas Securities
New York
$857K -$1.35M -38,146 -67%
CCIA
131
Campbell & Co Investment Adviser
Maryland
$828K +$635K +17,973 New
ASRS
132
Arizona State Retirement System
Arizona
$808K +$109K +3,074 +21%
Allianz Asset Management
133
Allianz Asset Management
Germany
$801K +$148K +4,200 +32%
TD Asset Management
134
TD Asset Management
Ontario, Canada
$748K +$573K +16,230 New
Balyasny Asset Management
135
Balyasny Asset Management
Illinois
$730K +$560K +15,851 New
Zurich Cantonal Bank
136
Zurich Cantonal Bank
Switzerland
$718K +$140K +3,961 +34%
AI
137
Atom Investors
Texas
$702K +$539K +15,247 New
UOC
138
UBS O'Connor
Illinois
$676K -$1.2M -34,000 -70%
Handelsbanken Fonder
139
Handelsbanken Fonder
Sweden
$649K – – –
Teacher Retirement System of Texas
140
Teacher Retirement System of Texas
Texas
$644K -$15.2K -430 -3%
LCM
141
Legato Capital Management
California
$545K +$5.48K +155 +1%
SACTSONJ
142
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$507K – – –
Public Employees Retirement Association of Colorado
143
Public Employees Retirement Association of Colorado
Colorado
$490K – – –
AAM
144
Advisors Asset Management
Colorado
$480K +$8.06K +228 +2%
EWM
145
Elmwood Wealth Management
California
$464K – – –
BC
146
Birchview Capital
Vermont
$461K – – –
GCM
147
Ghisallo Capital Management
Massachusetts
$461K +$353K +10,000 New
AssetMark Inc
148
AssetMark Inc
California
$458K +$100K +2,835 +40%
GC
149
Guggenheim Capital
Illinois
$439K -$56.6K -1,603 -14%
MAP
150
Moody Aldrich Partners
Massachusetts
$420K – – –
4 5
6
7 8

XENE Hedge Fund Activity: Q4 2023 in Review

204 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Xenon Pharmaceuticals (XENE) for Q4 2023, worth a combined $3.33B — up 59% from $2.1B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new XENE positions and 19 closed out — a net gain of 27 holders — while 86 added to existing stakes and 51 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $86M. The largest seller was BVF Inc, cutting an estimated $33.1M.

  • 204 institutional investors held Xenon Pharmaceuticals (XENE) as of Q4 2023, up from 180 in Q3 2023.
  • Funds reported $3.33B of Xenon Pharmaceuticals stock for Q4 2023, up 59% quarter-over-quarter.
  • 46 funds opened new Xenon Pharmaceuticals positions in Q4 2023 and 19 closed out, a net change of +27 holders.
  • The largest Xenon Pharmaceuticals buyer in Q4 2023 was Wellington Management Group, an estimated $86M added.
  • The largest Xenon Pharmaceuticals seller in Q4 2023 was BVF Inc, an estimated $33.1M sold.

Based on aggregated 13F filings for Q4 2023.